EX-12.1 2 ex12_112312013.htm EXHIBIT 12.1 RATIO
Exhibit 12.1
 
Progenics Pharmaceuticals, Inc.
Ratio of (Loss) Earnings to Combined Fixed Charges and Preferred Stock Dividends
(in thousands)
 
 
  
Years Ended December 31,
  
 
  
2013
    
2012
    
2011
    
2010
    
2009
  
Determination of (loss) earnings:
  
   
   
   
   
 
(Loss) income from operations
  
$
(42,934
)
  
$
(35,431
)
  
$
10,381
    
$
(69,820
)
  
$
(30,612
)
Add:
                                        
Fixed charges
    
710
      
410
      
695
      
709
      
555
  
 
                                        
(Loss) earnings, as adjusted
  
$
(42,224
)
  
$
(35,021
)
  
$
11,076
    
$
(69,111
)
  
$
(30,057
)
 
                                        
Fixed charges:
                                        
 
                                        
Estimate of interest within rental expense
    
710
      
410
      
695
      
709
      
555
  
 
                                        
Fixed charges
  
$
710
    
$
410
    
$
695
    
$
709
    
$
555
  
 
                                        
Preferred stock dividends
  
$
-
    
$
-
    
$
-
    
$
-
    
$
-
  
 
                                        
Ratio of (loss) earnings to fixed charges and preferred stock dividends
    
*
      
*
      
16
      
*
      
*
  
Coverage deficiency amount for total fixed charges and preferred stock dividends (1)
  
$
42,934
    
$
35,431
    
$
-
    
$
69,820
    
$
30,612
  

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
For the years ended 2009, 2010, 2012 and 2013, the Company's coverage ratio is less than one-to-one and it must generate additional earnings of these specified amounts to achieve a coverage ratio of 1:1.